Healthcare Industry - Medical - Pharmaceutical - Biotech in Stockholm, Sweden

The inherent heterogeneity of cancer - both inter-patient and intra-tumoral – remains a significant challenge in cancer modeling. With only 5% of cancer drugs successfully advancing to clinical trials, there is a critical need for more accurate and predictive models ..